Fred-Locke: Perspectives on CAR T as the SOC
When should CAR T be used in the treatment pathway?
When should patients be referred for CAR T-cell therapy?
How do you use interim PET scans?
What is your opinion on age-based cutoffs for CAR T-cell therapy?
Redefining outcomes in 2L LBCL: The ZUMA-7 study
